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Abstract
Nitro-fatty acids (NO2-FA) are pleiotropic modulators of redox signaling pathways. Their effects 
on inflammatory signaling have been studied in great detail in cell, animal and clinical models 
primarily using exogenously administered nitro-oleic acid. While we know a great deal about their 
signaling, endogenous NO2-FA formation and metabolism is relatively unexplored. This review 
will cover what is currently known regarding proposed mechanisms of formation, dietary 
modulation of endogenous NO2-FA levels, and pathways of metabolism and detection of NO2FA 
and corresponding metabolites.
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Nitro-Fatty Acid Formation and Metabolism
Metabolism of nitric oxide (•NO) and the production of nitrogen oxides under 
pathophysiological conditions generates nitrosating (R-NO) and nitrating (R-NO2) species 
that react with proteins, unsaturated fatty acids and thiol-containing small molecules such as 
glutathione (GSH) (1–4). The nitration of unsaturated fatty acids by the radical nitrogen 
dioxide (•NO2) generates electrophilic, bioactive lipids that form covalent Michael addition 
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adducts with nucleophilic amino acids, predominantly cysteine, found in transcriptional 
regulatory proteins and enzymes involved in metabolism, cell signaling and redox 
homeostasis (5,6). Post translational modification (PTM) by NO2-FA has been demonstrated 
to lead to profound functional changes (7,8). Because of this, there has been a growing 
interest over the last decade in the pleiotropic signaling of nitro-fatty acids (NO2-FA) in 
numerous disease models that has led to substantial increases in our understanding of the 
reactive pathways that lead to their formation as well as the complexity of their adsorption, 
metabolism, and accurate analysis (5). This review will summarize what we know thus far 
regarding the in vitro and in vivo formation and metabolism of electrophilic NO2-FA.
Nitration of fatty acids
Although much is known about the enzymatic and non-enzymatic oxidation of unsaturated 
fatty acids (9–13), fatty acid nitration is less understood. The structural characteristics of the 
unsaturated fatty acid define the reaction products and their formation is largely dependent 
on the differing chemical activities between bis-allylic and conjugated diene systems. Two 
different mechanisms have been proposed for the nitration of polyunsaturated bis-allylic 
fatty acids (14). The first mechanism is initiated by radical (•OH, •OOH, •NO2) hydrogen 
abstraction from a bis-allylic carbon to yield an alkyl radical (Figure 1A-a). This is a 
common reaction in the formation of other non-enzymatic lipid oxidation products including 
isoprostanes and hydroperoxides (11). Hydrogen abstraction is followed by double bond 
rearrangement and the insertion of molecular oxygen (O2) to yield a peroxyl radical or 
insertion of •NO2 to generate the non-electrophilic nitroalkane-alkene product (Figure 1A-b) 
(15). The second mechanism for bis-allylic polyunsaturated fatty acid nitration is the direct 
addition of •NO2 to generate a carbon-centered radical (Figure 1A-c). This radical can be 
oxidized further with or without •NO2 to form the electrophilic nitro-alkene (Figure 1A-e, d, 
f). Reacting with another molecule of •NO2 can form an unstable nitro-nitrito or dinitro 
compound that will rapidly decompose (releasing HNO2) to form an electrophilic nitro-
alkene (Figure 1A-f) (16). However, biological or physiological conditions seem to be 
unfavorable for the in vivo generation of electrophilic products from the bis-allylic-
containing fatty acids (i.e. linoleic and arachidonic) through the proposed mechanisms (17). 
While these NO2-FA species have been observed under a few varying conditions, none have 
been as extensively characterized and observed as often as nitro-conjugated linoleic acid 
(NO2-cLA). Studies consistently show nitration of cLA as the major NO2-FA formed in 
murine studies and human clinical trials (17–19).
Endogenous nitro fatty acid formation in animal models
During the last decade, important advances in the knowledge of in vitro and in vivo lipid 
nitration have been achieved. In this regard, the first relevant report for the in vivo formation 
of NO2-FA was in a murine model of focal cardiac ischemia-reperfusion (I/R) (20). In this 
model, the profile of NO2-FA detected was attributed to nitration of oleic acid (NO2-OA) 
and linoleic acid (NO2-LA), predominantly the trans-NO2-LA isoform. The formation of 
NO2-FA was a consequence of the reoxygenation-induced tissue damage that involves 
hypoxia, acidification and the formation of reactive oxygen and nitrogen species; a process 
that was not observed when myocardial ischemia occurred without reperfusion. Similarly, 
Nadtochiy et al. demonstrated the presence of NO2-FA in the experimental model of 
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ischemic preconditioning (IPC) in isolated rat hearts; however, the nitration products 
differed from the nitrated products obtained in the I/R model. Thus, while a partially 
characterized trans-NO2-LA was identified in cardiac tissue of the I/R model, the cis-NO2-
LA conformation was primarily measured in addition to NO2-OA in the IPC model. Initially, 
isobaric cis or trans bis-allylic LA (18:2) were designated as the substrate for in vivo 
nitration reactions; however, using high resolution liquid chromatography mass spectrometry 
(LC-MS), it was established that nitration preferentially occurs on the isomer of LA 
characterized by conjugated double bonds (cLA) instead of the bis-allylic methylene group 
present in LA (17). Thus, initial identification of nitration products were incorrectly 
identified as cis- and trans-isomers of LA and the retrospective analysis of the original 
samples from Rudolph’s animal model of myocardial focal I/R confirmed the presence of 
NO2-cLA (17). The conjugated dienes (principally 9-cis, 11-trans-cLA and 10-trans, 12-cis-
cLA isomers) are the main endogenous targets for in vivo nitration and display reactivity 
with •NO2 ~5 orders of magnitude higher than the bis-allylic LA (9-cis, 12-cis-LA) (17). 
Both the bis-allylic and conjugated-diene configuration allows for direct addition of •NO2; 
however, the conjugated system allows for the direct addition at the C-9 or C-12 positions 
and to a lesser extent at C-10 and C-11 positions, thus generating a delocalized allylic 
radical that is more stable than its bis-allylic counterpart (21). After •NO2 addition (Figure 
1B-a), this radical could follow several mechanisms of reaction; i) oxidation of the radical to 
reform the conjugated diene system with a vinyl NO2 group (Figure 1B-b), ii) the addition 
of a second •NO2 to the allyl radical intermediate, yielding an unstable dinitro or nitro-nitrito 
product. The nitrito would undergo rapid decomposition (releasing HNO2) to form a vinyl 
nitro product (Figure 1B-c), and iii) oxidation of the NO2-cLA radical intermediate to a 
nitro-peroxy followed by reduction of the peroxy to an alkoxy radical mediated by the 
oxidation of •NO to •NO2. This intermediate undergoes another round of reduction to the 
final product, nitro-hydroxy-OA (NO2-OH-OA) whereas an environment with higher 
oxygen tension would promote the formation of nitro-oxo-OA (NO2-oxo-OA) (Figure 1B-
d). These species expand the profile of fatty acids nitrated by •NO2 and increases the 
diversity of molecules that can impact in the biological function of NO2-FA (17). 
Oxygenated nitro fatty acids have not been well characterized in animal models or human 
trials and warrant further investigation.
The biological significance of the cLA findings were tested in a series of in vitro and in vivo 
experiments that involved the generation of the nitrating species •NO2 through (a) reaction 
of •NO with superoxide (O2•−) to yield peroxynitrite (ONOO−) and its homolytic cleavage 
products (•NO2 and •OH), (b) the one electron oxidation of nitrite (NO2−) by heme 
peroxidases (i.e. myeloperoxidase), (c) direct nitration by •NO2 gas, and (d) the acid-
catalyzed protonation of NO2− to HNO2 followed by its oxidation to •NO2 (22). This 
complex set of reactions demonstrates a variety of different nitrating pathways, yet •NO2 is 
the main intermediate in most of these reactions. Nitration of cLA was achieved in the 
cellular environment through inflammatory activated macrophages and also in the gastric 
lumen after oral administration of cLA and NO2− as was reflected by the increase of the 
endogenous levels in plasma and urine of treated mice (17,23). This mechanism may involve 
the protonation of NO2− to HNO2 and yields the nitrating •NO2 from dinitrogen trioxide 
(N2O3) and dinitrogen tetroxide (N2O4) homolysis, a process that is favored by the acidic 
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condition of gastric compartment leading to nitration of cLA in the gastrointestinal tract (5). 
These concepts are of significance to other cellular or tissue compartments with acidic pH 
that can support NO2− protonation (pKa 3.4) to HNO2 such as lysosomes, ischemic or 
inflammatory tissue and mitochondria (17,24).
NO in nitration and nitrosation reaction.
In this complex scenario where NO2−/•NO2 participate extensively in the mechanisms of 
lipid nitration, it is important to note that •NO does not participate as a direct nitrating 
species, rather its autoxidation gives rise to the nitrating intermediate •NO2 (25). In this 
context, Vitturi and coworkers showed that •NO was essential for •NO2-mediated cLA 
nitration induced by LPS and INFγ macrophage activation. Incubation of activated 
macrophages with a selective inhibitor of iNOS (1400W) in the presence of NO2− abolished 
cLA nitration revealing that •NO is required for cellular NO2−-dependent nitration (23). 
Using an experimental strategy with stable isotopes of nitrogen (15N and 14N) the authors 
described incorporation of 15N into both 15NO2-cLA (nitration) and GS15NO (glutathione S-
nitrosation) as a result of a potential mechanism involving the oxidation of 15NO2− to 
15•NO2 (Figure 2A, reactions 1-4), followed by the reaction of 15•NO2 with 14•NO to 
generate N2O3 containing a mix of 15N and 14N. These are the first findings to show that the 
formation of symmetrical N2O3 is possible. The symN2O3 contains two equivalent nitroso 
groups connected to a central oxygen by identical N-O bonds that generate a random 
distribution of the 15N or 14N atom giving rise to 14•NO or 15•NO, thus accounting for 
15•NO2−-derived GS-15NO formation (Figure 2B). In the case of asymN2O3 the homolytic 
scission of the N-N bond would regenerate 14•NO and 15•NO2 that could not explain the 
formation GS-15NO from 15NO2−. Thus, two mechanisms can be predicted where NO2− can 
generate symN2O3; a) via oxidation of NO2− to •NO2 followed by reaction with •NO, or b) a 
direct nucleophilic substitution (Figure 2). Taken together, this report confirms previous 
findings and describes the concept that •NO oxidation plays an important role during in vivo 
nitration reactions and that nitration reactions are likely to occur anywhere S-nitrosation 
takes place (23).
These findings become relevant at neutral pH where NO2− cannot generate HNO2 and the 
formation of nitrating and nitrosating species may be the consequence of metal catalysis. 
Nitration of cLA was described in a mouse model of acute peritonitis induced by intra-
peritoneal injection of LPS and isotopically labeled 15N18O2−. In this study NO2-cLA was 
formed by endogenously generated 14•NO2, but the administration of 15N18O2− revealed a 
dose dependent generation of 15N18O2-cLA in addition to a scramble of isotopologues 
(15N18O-16O-cLA, 14N18O-16O-cLA and 15N16O-16O-cLA) indicating that endogenously 
generated •NO reacts with 15N18O2− to form symN2O3 in vivo (23). This result highlights a 
novel role for NO2•/•NO2/•NO system as a precursor of NO2-FA and nitrosating 
intermediates, independent of pH and the presence of metal centers, via the formation of 
symN2O3 and its stochastic homolysis. A deeper understanding of nitroalkene formation in 
animal models will aid in the clinical development of NO2-FA, especially in the context of 
using dietary supplements of their precursors (i.e. cLA and NO2−/NO3−) to drive 
endogenous formation and evoke their signaling potential (3,5).
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NO2-FA formation in humans
The reactivity, metabolism and distribution of NO2-FA make accurate quantification 
inherently challenging. Early reports of in vivo levels of NO2-FA described the detection of 
a NO2-FA profile that included nitrated species of palmitoleic (16:1), oleic (18:1), linoleic 
(18:2), linolenic (18:3), arachidonic (20:4) and eicosapentaenoic (20:5) acids. Also reported 
for the first time were quantitative values of free NO2-OA upwards of 600 nM and esterified 
levels that approximated 300 nM in human plasma (26). Several years later these reports 
were refuted by Tsikas et al. who developed a stable isotope gas chromatography mass 
spectrometry method to accurately and precisely quantify the 9-NO2- and 10-NO2-
regioisomers of NO2-OA in plasma (27). The levels reported were three orders of magnitude 
lower than the original report by Baker et al (27,28). Based on follow up studies and further 
investigation we now know these reports, which quantified sub-nanomolar levels of NO2-OA 
are more accurate. Additionally, numerous studies investigating fatty acid nitration in vitro 
and in animal models have provided a solid foundation for understanding the nitration of 
cLA in humans. Under basal metabolic conditions, normal plasma NO3− levels range from 
20-40 μM while NO2− levels are substantially lower (50-300 nM) (4). Conversion of NO3− 
to NO2− is an insufficient process in mammals as they lack the required nitrate reductases; 
however, commensal bacteria in the gastrointestinal tract and on body surfaces use NO3− as 
an alternative electron acceptor during anaerobic respiration to produce ATP (29). Dietary 
intake of leafy and root vegetables, and herbs account for 60-80% of total NO3− intake. 
Other sources include drinking water (15-20%) and other animal-based products (15-20%) 
in which NO3− and NO2− are used as preservatives (Figure 3) (4,30–33).
Diet is also the main source of cLA where it is found primarily in dairy products and meat 
and was originally recognized for its metabolic effects on obesity, body composition, insulin 
sensitivity, and its association with reduced risk of cardiovascular events (34). cLA is a 
product of microbiome-promoted isomerization of LA to cLA in humans and animals (35) 
and rumen also have bacteria with Δ9-desaturase activity capable of metabolizing vaccenic 
acid (trans-oleic acid) to cLA (36). The predominant dietary isomer is 9-cis, 11-trans-cLA 
whereas commercial preps made from sunflower oil contain a mixture of 9-cis, 11-trans and 
10-trans, 12-cis-cLA (34). Confirmed now by several studies, cLA is the primary 
endogenous fatty acid to be nitrated at levels 5 orders of magnitude higher than LA to form 
NO2-cLA (17). NO2-cLA is formed under basal metabolic conditions in humans and 
rodents. Furthermore, dietary intake or supplement administration can increase NO2-cLA 
levels most likely due to the mechanisms of nitration described above (18,37). Nitration of 
conjugated linolenic acid (cLna, punicic acid, 18:3) also occurs and is a primary fatty acid 
found in pomegranate (~72%); however, cLna is absorbed at much lower levels in the diet 
compared to cLA (38) (Figure 3).
To better understand how diet contributes to NO2-cLA formation and signaling, a pilot study 
administering oral 15N-labeled Na15NO3− (1 g) and Na15NO2− (20 mg) without (Trial 1) and 
with cLA (3 g, Trial 2) was conducted in healthy volunteers (18,39). Volunteers were 
randomized to either NO3− or NO2− (Trial 1) and after a ~7 day washout period subjects 
received the opposite nitrogen oxide. In Trial 2 cLA supplementation was introduced 
concurrently with NO3− or NO2− supplementation. The endogenous 14NO2-cLA and 15NO2-
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cLA derived from the dietary supplementation, along with corresponding metabolites, were 
measured in plasma and urine by LC-MS. In Trial 1, 15NO2-cLA was only detected in 
plasma at the 24 hr time point after 15NO3− administration. These results indicated that cLA 
is rate limiting and its simultaneous presence in the gastric compartment along with NO3- or 
NO2- is required for the formation of NO2-cLA. Hence, in Trial 2, simultaneous cLA 
supplementation led to the formation of 15NO2-cLA after both 15NO3− and 15NO2− 
administration at time points earlier than in Trial 1. 15NO2- + cLA resulted in detectable, 
sustained levels of 15NO2-cLA from 1 to 6 hr after supplementation where as 15NO2-cLA 
was detected 2 hr after 15NO3− + cLA supplementation and levels continued to increase over 
the 24 hr period. Formation of 15NO2-cLA after 15NO2− + cLA supplementation tracked 
with peak levels of free cLA in plasma. Urinary cysteine adducts of 14NO2-cLA, 15NO2-
cLA and β-oxidation metabolites were also measured, thus confirming the electrophilic 
reactivity of the parent molecules and metabolites (18).
In this study the clinical responses were investigated to explore the impact of dietary lipid on 
nitrogen oxide metabolism and cardiovascular responses. Dietary supplementation of 
15NO3− and 15NO2− support 15•NO formation as measured by electroparamagnetic 
resonance spectroscopy detection of 15NO-deoxyhemoglobin complexes. 15•NO formation 
resulted in decreased systolic and mean arterial blood pressures and inhibited platelet 
function in Trial 1. Co-administration of cLA in Trial 2 reduced plasma NO3− and NO2− 
levels, decreased 15•NO-deoxyhemoglobin formation, NO2− inhibition of platelet activation, 
and the vasodilatory properties of NO2− while enhancing the formation of 15NO2-cLA. Thus 
the co-administration of the dietary supplement, cLA, significantly redirects cardiac 
responses attributed to NO2−/•NO to alternate pathways (39).
The discovery of endogenous NO2-cLA formation in humans under basal conditions and its 
elevated formation and signaling during inflammation and metabolic stress expands the 
pharmacokinetics and scope of •NO signaling beyond guanylate cyclase-dependent cGMP 
production. Although mechanisms of NO2-cLA formation and signaling have been 
investigated in vitro and in animal models and to some extent now in humans, there is still 
much we do not know. Further studies are warranted to investigate how diet, precursor 
supplementation, and the microbiome influence NO2-cLA formation and signaling 
compared to the administration of the pre-formed NO2-FA as the chemistry and pathway 
targets of NO3−/NO2− + cLA and NO2-cLA will greatly vary.
NO2-FA metabolism and distribution
The formation, metabolism, distribution and excretion of NO2-FA comprise a metabolic 
network capable of regulating steady state levels and signaling activity of these molecules 
under both basal and pathological conditions (Figure 4). The detection and measurement of 
NO2-FA and metabolites is inherently challenging because they form reversible covalent 
adducts with nucleophilic amino acids in proteins and cysteines in thiol containing 
molecules, such as GSH. Additionally as fatty acid species, they bind fatty acid binding 
pockets of carrier proteins like albumin (40) and participate in normal lipid metabolism and 
transport as they undergo saturation, β-oxidation, and are esterified into complex lipids (41–
44). A complete knowledge of their metabolism will be required to fully understand their 
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role as novel therapeutics for a variety of inflammatory diseases and recent studies are 
beginning to unravel their pharmacokinetic profile.
Similar to other fatty acids, saturation and β-oxidation products as well as NO2-FA-
Coenzyme A conjugates (NO2-FA-CoA) have been detected and well characterized by LC-
MS/MS (44). Many PK studies have utilized NO2-OA as a model NO2-FA since it has one 
double bond, thus making metabolism easier to characterize; although, increasing evidence 
suggests NO2-cLA metabolism follows a very similar pattern. The predominant free fatty 
acid species resulting from NO2-OA metabolism is nitro-stearic acid (NO2-SA) (44). NO2-
SA is a non-electrophilic nitroalkane formed from the saturation of the electrophilic double 
bond of NO2-OA by prostaglandin reductase 1 (PTGR1) (45). NO2-OA and NO2-SA can 
undergo several rounds of β-oxidation to form dinor (C16), tetranor (C14) and hexanor 
(C12) species. Similar metabolites have been described for NO2-cLA and these species have 
been detected in animal models and human plasma and urine under basal conditions and 
after supplementation (37). Other oxidized and nitrated products (e.g. nitro-nitrate, 
hydroxyl-NO2-FA) have been observed in various studies, but have not been explored in 
detail (46–48) (Figure 4).
A recent study gave an even more detailed report of NO2-FA metabolism and discovered 
taurine and sulfo- adducts along with ω-oxidation products as evidenced by dicarboxylic 
metabolites of reduced and electrophilic NO2-FA (49). Many of these products are found in 
both rodents and humans. NO2-FA readily form adducts with GSH and these adducts are 
exported from cells by multi-drug resistance transporters (50,51) and metabolites of GSH 
adduction are detected in urine as NO2-FA adducts of N-acetylcysteine and cysteine (37,49). 
These products are in equilibrium with free NO2-FA and corresponding metabolites in urine 
and can be readily displaced by thiol reaction with mercury chloride, increasing the free 
NO2-FA pool by an order of magnitude (37) (Figure 4).
The intricacies of NO2-FA metabolism and distribution are slowly being unraveled, as the 
incorporation of NO2-FA into complex lipids in cells and in vivo have been reported (Figure 
4). The formation of NO2-FA-containing triglycerides (TG) have been analyzed during in 
vitro acidic gastric digestion of TG and in adipocytes and rat plasma after NO2-OA 
supplementation (41) whereas endogenously formed NO2-FA and nitro-oxidized-containing 
phospholipids were detected in isolated cardiac mitochondria and cardiomyoblasts in a type 
1 diabetes mellitus animal model (48). These data demonstrate that NO2-FA-containing 
complex lipids can be generated after gastric digestion and inflammatory conditions.
An exhaustive quantitative body distribution analysis of radiolabeled [14C]-10-NO2-OA has 
been reported after oral administration in rats. Upon absorption, radioactivity was mainly 
distributed in kidney, liver, lungs, and heart, while long lasting accumulation was detected in 
brown and white adipose tissue over two weeks (42). However, the radioactivity measured in 
tissues by autoradiography could result from the [14C]-10-NO2-OA or its 14C-containing 
metabolites. To better understand NO2-OA metabolism and incorporation profiling into 
complex lipids, fractionated lipid classes of adipocytes and murine adipose tissue 
supplemented with NO2-OA were hydrolyzed and analyzed by HPLC-MS/MS. Interestingly, 
it was demonstrated that non-electrophilic NO2-OA metabolites, such as NO2-SA, were 
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preferentially esterified into TGs, while NO2-OA was incorporated into monoglycerides 
(MG) and diglycerides (DG) to a larger extent. This trend was further confirmed by 
supplementing adipocytes with NO2-cLA, NO2-LnA and NO2-SA. In this regard, the 
differential incorporation into MG+DG and TG of NO2-FA may be a consequence of their 
cellular availability, trafficking, and metabolism. In fact, the free intracellular pool of 
unsaturated NO2-FA is influenced by the electrophilic reactivity toward GSH and the 
formation of NO2-FA-GSH adducts, which are exported extracellularly by the multi-drug 
resistance proteins (50,52). In addition, intracellular NO2-FA are metabolized by tissue-
specific PTGR1 and long-chain acyl-CoA synthetase (ACSL) isoforms, generating saturated 
NO2-FA and NO2-FA-CoA species, respectively. Of note, ACSL isoforms have shown FA 
preferences (53) and could differentially esterify NO2-FA to form the CoA derivatives. 
Furthermore, the resultant NO2-FA-CoA may be preferentially used by different enzymes to 
generate phospholipids and glycerolipids. Then, the esterification of unsaturated NO2-FA 
into MG+DG fractions may generate a depot of potentially bioactive lipids, which could 
store and release electrophilic signaling mediators following an inflammatory response. 
Instead, the incorporation of saturated NO2-FA into TG fractions confirms their role as depot 
of inactive non-electrophilic metabolites. Esterified NO2-OA was ~18× more abundant in 
MG + DG vs. TG. The profile for NO2-cLA was similar to NO2-OA; however, overall 
esterification was 10-20% lower. Overall there were lower levels of incorporation into 
phospholipids compared to glycerolipids (41). These data demonstrate that NO2-FA and 
metabolites are distributed and incorporated into complex lipids, which can release 
electrophilic species after lipase hydrolysis and be delivered to remote tissue as lipoproteins, 
thus modulating cell homeostasis and tissue signaling.
Conclusions and Future Studies
The mechanisms of fatty acid nitration in vivo remain unclear; however, during recent years 
important advances have been made to elucidate the molecular intermediaries involved in 
nitration, its molecular targets and the resulting reaction products. Confirmation of cLA as 
the primary endogenous NO2-FA, correct measurement of free endogenous NO2-OA as well 
as new analyses of NO2-FA incorporation into complex lipids have helped shape the overall 
picture of NO2-FA formation and have provided better insight into the pharmacokinetics and 
pharmacodynamics of these pleiotropic anti-inflammatory therapies. Analysis of excreted 
radioactivity and metabolites in urine showed that 10-NO2-OA is extensively absorbed and 
rapidly metabolized within 24 hr (49). Future studies focused on NO2-FA intestinal 
absorption and the evaluation of hepatic (first-pass) metabolism is required as they need to 
solve the discrepancy between initial reports of NO2-OA bioavailability (~6%) (unpublished 
data) and the 35% urinary recovery reported in the [14C]-NO2-OA rat study (49). It may be 
that a significant portion of NO2-FA is stored in complex lipids and distributed throughout 
various tissues. These studies along with further characterization of novel NO2-FA 
metabolites and the investigation of next generation NO2-FA derivatives (54) as therapeutics 
will continue to expand our knowledge of the formation and metabolism of this pleiotropic 
class of therapeutic signaling molecules.
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Highlights
• Nitro-Fatty Acid (NO2-FA) formation is highly dependent on environmental 
factors including pH, oxygen tension and the presence of reactive species.
• NO2-cLA is the most abundant, endogenous NO2-FA.
• NO2-cLA is generated during metabolism and under conditions of 
inflammatory stress.
• Absolute measurement of NO2-FA is complicated by protein adduction, 
metabolism (reduction, β-oxidation, conjugation), and incorporation into 
complex lipids.
Buchan et al. Page 13
Nitric Oxide. Author manuscript; available in PMC 2019 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1: Proposed mechanisms of NO2-FA formation.
(A) NO2-FA formation from bis-allylic unsaturated fatty acids. (B) Nitration of conjugated 
linoleic acid. Asterisk indicate reactive electrophilic carbons.
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Figure 2: Generation of symN2O3.
(A) From NO2− oxidation to form •NO2 followed by reaction with •NO (B) or direct 
nucleophilic substitution.
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Figure 3: Dietary intake alters endogenous NO2-FA formation.
Nitrate (NO3−), nitrite (NO2−) and fatty acids such as oleic (OA, 18:1), conjugated linoleic 
(cLA, 18:2) and linolenic (cLnA,18:3) acid are found in dietary sources including 
vegetables, seeds and oils, meat and dairy. Further metabolism of NO3−and NO2− results in 
multiple nitrogen oxides including nitrogen dioxide (•NO2). Fatty acids most susceptible to 
nitration by •NO2 are those with a conjugated diene structure. Due to its abundance in the 
diet, cLA is the predominant endogenous fatty acid that is nitrated to form NO2-cLA.
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Figure 4: Routes of NO2-FA metabolism.
NO2-FA form reversible covalent adducts with reactive thiols and can also be incorporated 
into complex lipids. Free species of NO2-FA and metabolites are detected in plasma, tissue 
and urine. NO2-FA are reduced to non-electrophilic nitroalkanes by prostaglandin reductase 
and both nitroalkanes and alkenes undergo β-oxidation. In urine dicarboxylic acids resulting 
from ω oxidation were found as well as taurine and GSH derived conjugates.
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